Atlas Trials

Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects

Clinical trial NCT06151808 · COMPLETED

Trial details

NCT number
NCT06151808
Sponsor
Sinotau Pharmaceutical Group
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2022-09-01
Primary completion
2023-11-28
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.